omalizumab biologic indications
Selected indexed studies
- Role of Biologics in Asthma. (Am J Respir Crit Care Med, 2019) [PMID:30525902]
- Biologic Therapy in Pediatric Chronic Rhinosinusitis: A Systematic Review. (Otolaryngol Head Neck Surg, 2024) [PMID:38488239]
- Current Perspectives on Severe Drug Eruption. (Clin Rev Allergy Immunol, 2021) [PMID:34273058]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Combined use of Omalizumab and dupilumab: safety and efficacy data from a large academic center. (2025) pubmed
- Biologic Therapy in Pediatric Chronic Rhinosinusitis: A Systematic Review. (2024) pubmed
- Therapeutic monoclonal antibodies in allergy: Targeting IgE, cytokine, and alarmin pathways. (2024) pubmed
- Role of Biologics in Asthma. (2019) pubmed
- Current Perspectives on Severe Drug Eruption. (2021) pubmed
- Monoclonal Antibodies (Biologics) for Allergic Rhinitis, Asthma, and Atopic Dermatitis During Pregnancy and Lactation. (2023) pubmed
- Biologic and small molecule therapies in chronic spontaneous urticaria: an update. (2025) pubmed
- Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database. (2024) pubmed
- Biologics in allergology and clinical immunology: Update on therapies for atopic diseases, urticaria, and angioedema and on safety aspects focusing on hypersensitivity reactions. (2024) pubmed
- Achieving remission in severe asthma. (2025) pubmed